Andrea Necchi
@AndreaNecchi
Associate Professor @MyUniSR - Head of Genitourinary Medical Oncology @SanRaffaeleMI - Vice President @GTumors
06-04-2012 19:53:04
2,2K Tweets
3,3K Followers
1,0K Following
📝 Another negative trial of an FGFR inhibitor in later line UC: Derazantinib +/- atezo in metastatic UC with activating FGFR aberrations | including a cohort of FGFRi post FGFRi ylt Ospedale San Raffaele Università Vita-Salute San Raffaele UroToday.com Patrizia Giannatempo academic.oup.com/jncics/article…